Picard Medical Inc (PMI)
AMEXHealth CareMedical - DevicesSnapshot 2026-11-04
AMEXHealth CareMedical - DevicesSnapshot 2026-11-04
QuarterlyIQ Insights · PMI
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance sits well below its industry cohort — worth keeping an eye on, though it has not freshly broken.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -77.2% |
| Our one-year growth estimate | diamond | -7.5% |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-11-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Growth built into the price is above our model estimate.
The price assumes 69.7 percentage points less one-year growth.
The one-year revenue growth assumption on Valuation.
Model as of 2026-11-04 · Compared with 29 industry peers
PMI — CEO transition
Dated 2026-11-03
CEO — Richard Fang: The filing announces the permanent appointment of the Interim CEO, who is a former CEO and current Board Chairman, representing an internal succession rather than a departure.
Why it matters: PMI issued $1.0 million in notes in September and has raised capital before. More deals could add debt or dilute shares.
Worry ifA new filing shows PMI issued another convertible note or sold more shares.
Less concerning ifNo new note or share sale appears in filings through the next earnings report.
Why it matters: PMI received several notices and has an accepted plan. Regaining compliance would close a key listing risk.
Supportive ifNYSE American confirms PMI now meets its listing standards again.
Worry ifNYSE American says PMI missed a plan deadline or remains out of compliance.
Why it matters: Revenue and gross profit improved through 2026-Q2, but PMI still had operating losses. The next report tests if progress continues.
Watch forQ3 revenue tops $2.95 million and gross profit tops $616,000.
Also watch forQ3 revenue falls below $2.95 million or gross profit falls below $616,000.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$604 on $10,000 · ±6.0% | How much price usually moves either way. |
| Bad day | $1,888 loss on $10,000 · 18.9% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $9,762 loss on $10,000 · 97.6% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.